This inventor holds 1 USPTO granted patent. Top assignee: Helmholtz-Zentrum Fur Infektionsforschung Gmbh. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Sangeun Lee - Innovator in Polymer-Cargo-Complexes
Introduction
Sangeun Lee is a prominent inventor based in Saarbruecken, Germany. He has made significant contributions to the field of polymer science, particularly in the development of polymer-cargo-complexes. His innovative work focuses on the intersection of materials science and biotechnology.
Latest Patents
Sangeun Lee holds a patent for "Polymer-cargo-complexes comprising cross-linked copolymers and cargo molecules." This invention includes polymer-cargo-complexes that feature cross-linked copolymers and cargo molecules bound to the copolymers through electrostatic interactions. The non-medical applications of this technology include transfection, as well as a kit that incorporates such polymer-cargo-complexes. Furthermore, these polymer-cargo-complexes are designed for therapeutic uses, particularly in gene therapy and peptide/protein drug delivery. The patent also outlines a method for preparing these polymer-cargo-complexes.
Career Highlights
Sangeun Lee is affiliated with Helmholtz-Zentrum für Infektionsforschung GmbH, where he continues to advance his research in polymer applications. His work has garnered attention for its potential impact on therapeutic strategies and drug delivery systems.
Collaborations
Sangeun collaborates with esteemed colleagues such as Brigitta Loretz and Claus-Michael Lehr. Their combined expertise enhances the research environment and fosters innovation in their respective fields.
Conclusion
Sangeun Lee's contributions to the field of polymer science and his innovative patent on polymer-cargo-complexes highlight his role as a key inventor in advancing therapeutic technologies. His work promises to influence future developments in gene therapy and drug delivery systems.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile